O'Neill Institute
State Action to Lower Prescription Drug Prices: Navigating Patent PreemptionPrescription Drug Affordability Boards
Issue Metadata
More Prescription Drug Affordability tracked topics
-
Orange Book Patent Listings
Cases Tracked: 4
-
Product Specific Access Laws
Cases Tracked: 4
-
Price Gouging Laws
Cases Tracked: 3
-
Transparency Laws
Cases Tracked: 2
Dive Deeper
O'Neill Institute
Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription DrugsMore Issues
- 340B Program 15 cases
- Affordable Care Act 65 cases 6 Topics
- Anticompetitive Practices 20 cases
- Artificial Intelligence 3 cases
- Consumer Protections 10 cases
- Cost Containment 12 cases
- Equity 49 cases 1 Topics
- ERISA 15 cases
- Federal Health Funding 31 cases 4 Topics
- Health Information 2 cases
- Medicare Advantage 4 cases
- Medicare Drug Price Negotiation 20 cases
- No Surprises Act 34 cases 4 Topics
- Reproductive Health 39 cases 5 Topics
- Site-Neutral Payments 9 cases
- Transparency 5 cases